Tokyo, Nov. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059678) titled 'Skin Condition Data Collection Study' on Nov. 7.
Study Type:
Observational
Primary Sponsor:
Institute - CPCC Company Limited
Condition:
Condition - Male/female adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To collect basal skin condition data
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - 1. Males and females aged 20 years to less than 60 years from informed consent to the end of the study.
2. Individuals who are able to present to the designated facility on the scheduled visit day for Health Examination 2.
3. Individuals who self-aware of having dry skin.
4. Individuals who are able to give informed consent to participate in this study after receiving a detailed explanation of the protocol and understanding its contents.
Key exclusion criteria - 1. Subjects whose systolic blood pressure is less than 90 mmHg
2. Subjects who are participating in other clinical studies, or who finished clinical study within 4 weeks.
3. Subjects who are applicable to following items
a) Subjects with disease on heart, liver, kidney or other organs complication.
b) Subjects with a previous history of disease on circulatory organs.
c) Subjects who are contracting diabetes.
d) Subjects with a history of cancer, tuberculosis, or other serious illness
4. Smoker
5.Subjects who drink a lot.
6. Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Target Size - 140
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 10 Month 27 Day
Date of IRB - 2025 Year 10 Month 24 Day
Anticipated trial start date - 2025 Year 11 Month 08 Day
Last follow-up date - 2026 Year 01 Month 21 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068020
Disclaimer: Curated by HT Syndication.